BSE announces listing of further securities issued under ESOP/ESOS by 16 companies including ICICI Bank, Wipro, Federal Bank, and others, effective November 27, 2025.
Impact
Low
Severity
Low
Justification
Routine listing of ESOP/ESOS shares with no lock-in period. Minor impact on share capital and no material effect on trading or compliance requirements.
BSE announces the listing and admission for trading of further securities issued under employee stock option schemes by 16 companies, effective November 27, 2025.
Impact
Low
Severity
Low
Justification
Routine listing of ESOP/ESOS shares with no lock-in period. These are incremental shares from employee stock options, representing small dilution across 16 companies. No material market impact expected.
BSE demat auction settlement No. 762 listing securities available for auction on November 25, 2025.
Impact
Low
Severity
Low
Justification
Routine demat auction notice listing securities available for auction settlement. Limited impact to general market participants, primarily relevant to clearing members and specific auction participants.
BSE demat auction settlement listing securities and quantities due for delivery on November 25, 2025.
Impact
Low
Severity
Medium
Justification
Routine demat auction settlement affecting specific delivery obligations; limited market-wide impact but important for involved trading members and investors.
BSE Demat Auction for Settlement No. 760 dated November 21, 2025, listing securities and quantities for auction settlement.
Impact
Medium
Severity
Medium
Justification
Demat auction settlement affecting multiple securities across various sectors. Medium impact as it involves routine settlement process for 89 different scrips with varying quantities.
BSE demat auction for settlement number 760 listing securities and quantities available for auction across multiple scrips.
Impact
Low
Severity
Low
Justification
Routine demat auction notice for settlement 760 listing securities available for auction. Standard operational notice with limited market-wide impact, affecting only specific scrips with delivery shortages.